Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
OtherPractice

Newer iron supplements for anemia

Samantha Moe, Allan K. Grill and G. Michael Allan
Canadian Family Physician August 2019, 65 (8) 556;
Samantha Moe
Clinical Evidence Expert for the College of Family Physicians of Canada (CFPC) in Mississauga, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan K. Grill
Assistant Professor in the Department of Family and Community Medicine at the University of Toronto, Lead Physician at the Markham Family Health Team, and part-time Physician Advisor at the CFPC.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Michael Allan
Director of Programs and Practice Support for the CFPC and Professor in the Department of Family Medicine at the University of Alberta in Edmonton.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Clinical question

Are newer oral iron formulations (iron polysaccharide complex or heme iron polypeptide) better than ferrous salts for iron deficiency anemia (IDA)?

Bottom line

Newer iron formulations appear to be inferior. Ferrous salts improve hemoglobin (Hb) levels by up to 10 to 20 g/L more, with IDA resolution in perhaps 1 in 5 more patients at 3 months. Evidence that newer formulations have fewer adverse effects is inconsistent.

Evidence

The following evidence is from RCTs. Differences are statistically significant unless otherwise indicated.

  • Iron polysaccharide (Niferex) compared with ferrous fumarate (both about 150 mg/d elemental iron) in 80 patients (92% female, mean age 39)1: After 12 weeks, ferrous fumarate improved Hb levels (28.4 g/L) more than iron polysaccharide (6 g/L) did, and patients had better serum ferritin levels, mean corpuscular volume, and transferrin saturation but more nausea (31% vs 3%).

  • Iron polysaccharide (NovaFerrum) compared with ferrous sulfate (both 3 mg/kg/d elemental iron) in 80 children (mean age 23 months)2: After 12 weeks, ferrous sulfate improved Hb levels more (10 g/L), resolved IDA more often (29% vs 6%, number need to treat of 5), and caused less diarrhea (35% vs 58%).

  • Smaller trials of adults (n = 43)3 and premature infants (n = 32)4 comparing iron polysaccharide and ferrous salts found no differences in Hb improvement at 4 to 6 weeks.

  • Dialysis patients: At 6 months, ferrous salts were no different from newer formulations in transferrin saturation5,6 or proportion of iron-replete patients.5 Ferritin levels (about 160 µg/L) were better with ferrous sulfate than with heme iron (Proferrin ES).5

  • Post–gastric bypass (n = 14)7: Ferrous sulfate improved Hb levels after 8 weeks, but heme iron (Proferrin ES) did not.

  • Blood donors (n = 97)8 and pregnant patients (n = 90)9: Heme iron with ferrous fumarate (Hemofer) was no different from higher-dose ferrous fumarate alone8,9; ferrous fumarate alone caused more constipation (35% vs 14%).8

Context

  • Trials had multiple limitations: underpowered,2,4,6–9 multiple outcomes,1–9 and not intention-to-treat.1,2,5

  • Approximate costs per month for 100 mg of elemental iron per day10: ferrous fumarate or sulfate (generics, $5 to $10), ferrous fumarate (Palafer, $35), and iron polysaccharide complexes (Feramax, $35).

Implementation

The cause of IDA should be determined. Treatment with ferrous salts (100 to 200 mg/d elemental iron)11 might take up to 3 months to normalize Hb levels and replenish iron stores.12 Newer formulations are more expensive and do not appear to provide additional benefit. Gastrointestinal side effects are common; compliance might improve with lower doses, alternate-day dosing, or selecting ferrous gluconate or sulfate over fumarate.13 In patients who fail oral therapy or with poor oral absorption (eg, inflammatory bowel disease), intravenous iron can be considered.12,14

Notes

Tools for Practice articles in Canadian Family Physician are adapted from articles published on the Alberta College of Family Physicians (ACFP) website, summarizing medical evidence with a focus on topical issues and practice-modifying information. The ACFP summaries and the series in Canadian Family Physician are coordinated by Dr G. Michael Allan, and the summaries are co-authored by at least 1 practising family physician and are peer reviewed. Feedback is welcome and can be sent to toolsforpractice{at}cfpc.ca. Archived articles are available on the ACFP website: www.acfp.ca.

Footnotes

  • Competing interests

    None declared

  • The opinions expressed in Tools for Practice articles are those of the authors and do not necessarily mirror the perspective and policy of the Alberta College of Family Physicians.

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    1. Liu TC,
    2. Lin SF,
    3. Chang CS,
    4. Yang WC,
    5. Chen TP
    . Comparison of a combination ferrous fumarate product and a polysaccharide iron complex as oral treatments of iron deficiency anemia: a Taiwanese study. Int J Hematology 2004;80(5):416-20.
    OpenUrl
  2. 2.↵
    1. Piccinni L,
    2. Ricciotti M
    . Therapeutic effectiveness of an iron-polysaccharide complex in comparison with iron fumarate in the treatment of iron deficiency anemias. Panminerva Med 1982;24(3):213-20.
    OpenUrlPubMed
  3. 3.↵
    1. Powers JM,
    2. Buchanan GR,
    3. Adix L,
    4. Zhang S,
    5. Gao A,
    6. McCavit TL
    . Effect of low-dose ferrous sulfate vs iron polysaccharide complex on hemoglobin concentration in young children with nutritional iron-deficiency anemia: a randomized trial. JAMA 2017;317(22):2297-304.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Naude S,
    2. Clijsen S,
    3. Naulaers G,
    4. Daniels H,
    5. Vanhole C,
    6. Devlieger H
    . Iron supplementation in preterm infants: a study comparing the effect and tolerance of a Fe2+ and a nonionic FeIII compound. J Clin Pharmcol 2000;40(12 Pt 2):1447-51.
    OpenUrl
  5. 5.↵
    1. Barraclough KA,
    2. Brown F,
    3. Hawley CM,
    4. Leary D,
    5. Noble E,
    6. Campbell SB,
    7. et al
    . A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial. Nephrol Dial Transpl 2012;27(11):4146-53. Epub 2012 Sep 7.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Wingard RL,
    2. Parker RA,
    3. Ismail N,
    4. Hakim RM
    . Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin. Am J Kid Dis 1995;25(3):433-9.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Mischler RA,
    2. Armah SM,
    3. Craig BA,
    4. Rosen AD,
    5. Banerjee A,
    6. Selzer DJ,
    7. et al
    . Comparison of oral iron supplement formulations for normalization of iron status following Roux-EN-y gastric bypass surgery: a randomized trial. Obes Surg 2018;28(2):369-77.
    OpenUrl
  8. 8.↵
    1. Frykman E,
    2. Bystrom M,
    3. Jansson U,
    4. Edberg A,
    5. Hansen T
    . Side effects or iron supplements in blood donors: superior tolerance of heme iron. J Lab Clin Med 1994;123(4):561-4.
    OpenUrlPubMed
  9. 9.↵
    1. Eskeland B,
    2. Malterud K,
    3. Ulvik RJ,
    4. Hunskaar S
    . Iron supplementation in pregnancy: is less enough? A randomized, placebo controlled trial of low dose iron supplementation with and without heme iron. Acta Obstet Gynecol Scand 1997;76(9):822-8.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Kolber MR,
    2. Lee J,
    3. Korownyk C,
    4. Allan GM,
    5. Nickonchuk T
    . Price comparison of commonly prescribed pharmaceuticals in Alberta 2018. Edmonton, AB: Alberta College of Family Physicians; 2018. Available from: https://acfp.ca/wp-content/uploads/2018/03/ACFPPricingDoc2018.pdf. Accessed 2019 May 25.
  11. 11.↵
    1. Towards Optimized Practice.
    Iron deficiency anemia (IDA). Clinical practice guideline. Edmonton, AB: Towards Optimized Practice; 2018. Available from: www.topalbertadoctors.org/download/2256/IDA%20CPG.pdf?_20190405124948. Accessed 2019 Feb 3.
  12. 12.↵
    1. Goddard A,
    2. James M,
    3. McIntyre A,
    4. Scott B
    . Guidelines for the management of iron deficiency anemia. Gut 2011;60(10):1309-16. Epub 2011 May 11.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Cancelo-Hidalgo MJ,
    2. Castelo-Branco C,
    3. Palacios S,
    4. Haya-Palazuelos J,
    5. Ciria-Recasens M,
    6. Manasanch J,
    7. et al
    . Tolerability of different oral iron supplements: a systematic review. Curr Med Res Opin 2013;29(4):291-303. Epub 2013 Feb 6.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Johnson-Wimbley TD,
    2. Graham DY
    . Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol 2011;4(3):177-84.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 65 (8)
Canadian Family Physician
Vol. 65, Issue 8
1 Aug 2019
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Newer iron supplements for anemia
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Newer iron supplements for anemia
Samantha Moe, Allan K. Grill, G. Michael Allan
Canadian Family Physician Aug 2019, 65 (8) 556;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Newer iron supplements for anemia
Samantha Moe, Allan K. Grill, G. Michael Allan
Canadian Family Physician Aug 2019, 65 (8) 556;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Clinical question
    • Bottom line
    • Evidence
    • Context
    • Implementation
    • Notes
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Iron dosing frequency
  • Posologie du fer
  • Google Scholar

More in this TOC Section

Practice

  • Is 45 the new 50 in colorectal cancer screening?
  • Approach to diagnosis and management of childhood attention deficit hyperactivity disorder
  • Determining if and how older patients can safely stay at home with additional services
Show more Practice

Tools for Practice

  • Topical treatments for anal fissure
  • Antibiotic prophylaxis for urinary tract infection
  • Pediatric diarrhea and lactose products
Show more Tools for Practice

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2023 by The College of Family Physicians of Canada

Powered by HighWire